• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

    4/30/25 7:40:00 PM ET
    $BBN
    $BCAT
    $BCX
    $BDJ
    Finance Companies
    Finance
    Finance/Investors Services
    Finance
    Get the next $BBN alert in real time by email

    Today, BlackRock Resources & Commodities Strategy Trust (NYSE:BCX), BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ), BlackRock Energy and Resources Trust (NYSE:BGR), BlackRock Enhanced International Dividend Trust (NYSE:BGY), BlackRock Health Sciences Trust (NYSE:BME), BlackRock Health Sciences Term Trust (NYSE:BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE:BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE:BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE:CII), BlackRock Science and Technology Trust (NYSE:BST), BlackRock Science and Technology Term Trust (NYSE:BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE:BTX), BlackRock Capital Allocation Term Trust (NYSE:BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT) (collectively, the "Funds") paid the following distributions per share:

    Fund

    Pay Date

    Per Share

    BCX

    April 30, 2025

    $0.069700

    BDJ

    April 30, 2025

    $0.061900

    BGR

    April 30, 2025

    $0.097300

    BGY

    April 30, 2025

    $0.042600

    BME

    April 30, 2025

    $0.262100

    BMEZ

    April 30, 2025

    $0.173970

    BOE

    April 30, 2025

    $0.082700

    BUI

    April 30, 2025

    $0.136000

    CII

    April 30, 2025

    $0.141000

    BST

    April 30, 2025

    $0.250000

    BSTZ

    April 30, 2025

    $0.221810

    BTX

    April 30, 2025

    $0.084470

    BCAT

    April 30, 2025

    $0.284750

    ECAT

    April 30, 2025

    $0.303590

    Each of the Funds has adopted a managed distribution plan (the "Plan") to support a level monthly distribution of income, capital gains and/or return of capital, or in the case of BMEZ, BSTZ, BTX, BCAT and ECAT a monthly distribution based on an annual rate of 12% (for BMEZ, BSTZ and BTX) and 20% (for BCAT and ECAT) of the Fund's 12-month rolling average daily net asset value calculated 5 business days prior to declaration date of each distribution. The fixed amounts distributed per share or distribution rate, as applicable, are subject to change at the discretion of each Fund's Board of Directors/Trustees. Under its Plan, each Fund will distribute all available net income to its shareholders, consistent with its investment objectives and as required by the Internal Revenue Code of 1986, as amended (the "Code"). If sufficient income (inclusive of net investment income and short-term capital gains) is not available on a monthly basis, the Funds will distribute long-term capital gains and/or return capital to their shareholders in order to maintain a level distribution.

    Each Fund's estimated sources of the distributions paid April 30, 2025 and for its current fiscal year are as follows:

    Estimated Allocations as of April 30, 2025

    Fund

    Distribution

    Net Income

    Net Realized Short-Term Gains

    Net Realized Long-Term Gains

    Return of Capital

    BCX1

    $0.069700

    $0.014318 (21%)

    $0 (0%)

    $0 (0%)

    $0.055382 (79%)

    BDJ

    $0.061900

    $0.017213 (28%)

    $0 (0%)

    $0.044687 (72%)

    $0 (0%)

    BGR1

    $0.097300

    $0.009538 (10%)

    $0 (0%)

    $0 (0%)

    $0.087762 (90%)

    BGY1

    $0.042600

    $0.028033 (66%)

    $0 (0%)

    $0 (0%)

    $0.014567 (34%)

    BME

    $0.262100

    $0.033837 (13%)

    $0 (0%)

    $0.228263 (87%)

    $0 (0%)

    BMEZ1

    $0.173970

    $0.002915 (2%)

    $0 (0%)

    $0 (0%)

    $0.171055 (98%)

    BOE1

    $0.082700

    $0.032501 (39%)

    $0 (0%)

    $0.050199 (61%)

    $0 (0%)

    BUI1

    $0.136000

    $0 (0%)

    $0 (0%)

    $0.136000 (100%)

    $0 (0%)

    CII

    $0.141000

    $0.004268 (3%)

    $0 (0%)

    $0.136732 (97%)

    $0 (0%)

    BST1

    $0.250000

    $0 (0%)

    $0 (0%)

    $0.250000 (100%)

    $0 (0%)

    BSTZ

    $0.221810

    $0 (0%)

    $0 (0%)

    $0.221810 (100%)

    $0 (0%)

    BTX1

    $0.084470

    $0 (0%)

    $0 (0%)

    $0 (0%)

    $0.084470 (100%)

    BCAT1

    $0.284750

    $0.032379 (11%)

    $0 (0%)

    $0 (0%)

    $0.252371 (89%)

    ECAT1

    $0.303590

    $0.020000 (7%)

    $0 (0%)

    $0 (0%)

    $0.283590 (93%)

    Estimated Allocations for the Fiscal Year through April 30, 2025

    Fund

    Distribution

    Net Income

    Net Realized Short-Term Gains

    Net Realized Long-Term Gains

    Return of Capital

    BCX1

    $0.278800

    $0.077301 (28%)

    $0 (0%)

    $0 (0%)

    $0.201499 (72%)

    BDJ

    $0.247600

    $0.228951 (92%)

    $0 (0%)

    $0.018649 (8%)

    $0 (0%)

    BGR1

    $0.389200

    $0.109633 (28%)

    $0 (0%)

    $0 (0%)

    $0.279567 (72%)

    BGY1

    $0.170400

    $0.029453 (17%)

    $0 (0%)

    $0 (0%)

    $0.140947 (83%)

    BME

    $1.048400

    $0.041156 (4%)

    $0 (0%)

    $1.007244 (96%)

    $0 (0%)

    BMEZ1

    $0.705760

    $0 (0%)

    $0 (0%)

    $0 (0%)

    $0.705760 (100%)

    BOE1

    $0.330800

    $0.053333 (16%)

    $0 (0%)

    $0.174982 (53%)

    $0.102485 (31%)

    BUI1

    $0.544000

    $0.033995 (6%)

    $0 (0%)

    $0.289512 (53%)

    $0.220493 (41%)

    CII

    $0.564000

    $0 (0%)

    $0 (0%)

    $0.564000 (100%)

    $0 (0%)

    BST1

    $1.000000

    $0 (0%)

    $0 (0%)

    $0.745341 (75%)

    $0.254659 (25%)

    BSTZ

    $0.886520

    $0 (0%)

    $0 (0%)

    $0.886520 (100%)

    $0 (0%)

    BTX1

    $0.344000

    $0 (0%)

    $0 (0%)

    $0 (0%)

    $0.344000 (100%)

    BCAT1

    $1.149300

    $0.071752 (6%)

    $0 (0%)

    $0 (0%)

    $1.077548 (94%)

    ECAT1

    $1.224230

    $0.037283 (3%)

    $0 (0%)

    $0 (0%)

    $1.186947 (97%)

    1The Fund estimates that it has distributed more than its income and net-realized capital gains in the current fiscal year; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder's investment is paid back to the shareholder. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with ‘yield' or ‘income'. When distributions exceed total return performance, the difference will reduce the Fund's net asset value per share.

    The amounts and sources of distributions reported are only estimates and are being provided to you pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon each Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

    Fund Performance and Distribution Rate Information:

    Fund

    Average annual total return (in relation to NAV) for the 5-year period ending on 3/31/2025

    Annualized current distribution rate expressed as a percentage of NAV as of 3/31/2025

    Cumulative total return (in relation to NAV) for the fiscal year through 3/31/2025

    Cumulative fiscal year distributions as a percentage of NAV as of 3/31/2025

    BCX

    18.16%

    8.29%

    7.74%

    2.07%

    BDJ

    14.70%

    8.12%

    3.60%

    2.03%

    BGR

    23.08%

    8.00%

    8.34%

    2.00%

    BGY

    10.49%

    8.49%

    4.20%

    2.12%

    BME

    9.46%

    7.55%

    3.14%

    1.89%

    BMEZ

    5.14%

    13.66%

    (3.81%)

    3.48%

    BOE

    11.96%

    8.38%

    0.47%

    2.10%

    BUI

    11.63%

    7.27%

    0.91%

    1.82%

    CII

    15.65%

    8.46%

    (4.66%)

    2.12%

    BST

    12.35%

    8.73%

    (11.51%)

    2.18%

    BSTZ

    11.05%

    13.91%

    (14.50%)

    3.47%

    BTX*

    (16.50%)

    15.50%

    (18.99%)

    3.97%

    BCAT*

    4.81%

    22.00%

    0.00%

    5.57%

    ECAT*

    5.70%

    22.39%

    (2.06%)

    5.66%

    * Portfolio launched within the past 5 years; the performance and distribution rate information presented for this Fund reflects data from inception to 3/31/2025.

    Shareholders should not draw any conclusions about a Fund's investment performance from the amount of the Fund's current distributions or from the terms of the Fund's Plan.

    BlackRock Income Trust, Inc. (NYSE:BKT), BlackRock Debt Strategies Fund, Inc. (NYSE:DSU), BlackRock Floating Rate Income Strategies Fund, Inc. (NYSE:FRA), BlackRock Taxable Municipal Bond Trust (NYSE:BBN), BlackRock Floating Rate Income Trust (NYSE:BGT), BlackRock Corporate High Yield Fund, Inc. (NYSE:HYT), BlackRock Credit Allocation Income Trust (NYSE:BTZ), BlackRock Limited Duration Income Trust (NYSE:BLW), BlackRock Core Bond Trust (NYSE:BHK) and BlackRock Multi-Sector Income Trust (NYSE:BIT) have adopted a Plan to support a level monthly distribution of income, capital gains and/or return of capital. The fixed amounts distributed per share are subject to change at the discretion of each Fund's Board of Directors/Trustees. Under its Plan, each Fund will distribute all available net income to its shareholders, consistent with its investment objectives and as required by the Code. If sufficient income (inclusive of net investment income and short-term capital gains) is not available on a monthly basis, a Fund will distribute long-term capital gains and/or return capital to its stockholders in order to maintain a level distribution. Each of the above-listed Funds is currently not relying on any exemptive relief from Section 19(b) of the Investment Company Act of 1940, as amended (the "1940 Act"). Each Fund expects that distributions under the Plan will exceed current income and capital gains and therefore will likely include a return of capital. Each Fund may make additional distributions from time to time, including additional capital gain distributions at the end of the taxable year, if required to meet requirements imposed by the Code and/or the 1940 Act.

    Each Fund's estimated sources of the distributions paid April 30, 2025 and for its current fiscal year are as follows:

    Estimated Allocations as of April 30, 2025

    Fund

    Distribution

    Net Income

    Net Realized Short-Term Gains

    Net Realized Long-Term Gains

    Return of Capital

    BKT2

    $0.088200

    $0.035176 (40%)

    $0 (0%)

    $0 (0%)

    $0.053024 (60%)

    DSU2

    $0.098730

    $0.058014 (59%)

    $0 (0%)

    $0 (0%)

    $0.040716 (41%)

    FRA2

    $0.123840

    $0.074776 (60%)

    $0 (0%)

    $0 (0%)

    $0.049064 (40%)

    BBN2

    $0.092900

    $0.078256 (84%)

    $0 (0%)

    $0 (0%)

    $0.014644 (16%)

    BGT2

    $0.120280

    $0.069447 (58%)

    $0 (0%)

    $0 (0%)

    $0.050833 (42%)

    HYT2

    $0.077900

    $0.056821 (73%)

    $0 (0%)

    $0 (0%)

    $0.021079 (27%)

    BTZ2

    $0.083900

    $0.057213 (68%)

    $0 (0%)

    $0 (0%)

    $0.026687 (32%)

    BLW2

    $0.113200

    $0.082701 (73%)

    $0 (0%)

    $0 (0%)

    $0.030499 (27%)

    BHK2

    $0.074600

    $0.047834 (64%)

    $0 (0%)

    $0 (0%)

    $0.026766 (36%)

    BIT2

    $0.123700

    $0.077179 (62%)

    $0 (0%)

    $0 (0%)

    $0.046521 (38%)

     

    Estimated Allocations for the Fiscal Year through April 30, 2025

    Fund

    Distribution

    Net Income

    Net Realized Short-Term Gains

    Net Realized Long-Term Gains

    Return of Capital

    BKT2

    $0.352800

    $0.138632 (39%)

    $0 (0%)

    $0 (0%)

    $0.214168 (61%)

    DSU2

    $0.394920

    $0.240860 (61%)

    $0 (0%)

    $0 (0%)

    $0.154060 (39%)

    FRA2

    $0.495360

    $0.317372 (64%)

    $0 (0%)

    $0 (0%)

    $0.177988 (36%)

    BBN2

    $0.371600

    $0.321103 (86%)

    $0 (0%)

    $0 (0%)

    $0.050497 (14%)

    BGT2

    $0.481120

    $0.287292 (60%)

    $0 (0%)

    $0 (0%)

    $0.193828 (40%)

    HYT2

    $0.311600

    $0.230706 (74%)

    $0 (0%)

    $0 (0%)

    $0.080894 (26%)

    BTZ2

    $0.335600

    $0.231157 (69%)

    $0 (0%)

    $0 (0%)

    $0.104443 (31%)

    BLW2

    $0.452800

    $0.338064 (75%)

    $0 (0%)

    $0 (0%)

    $0.114736 (25%)

    BHK2

    $0.298400

    $0.197605 (66%)

    $0 (0%)

    $0 (0%)

    $0.100795 (34%)

    BIT2

    $0.494800

    $0.302066 (61%)

    $0 (0%)

    $0 (0%)

    $0.192734 (39%)

    2The Fund estimates that it has distributed more than its income and net-realized capital gains in the current fiscal year; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder's investment is paid back to the shareholder. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with ‘yield' or ‘income'. When distributions exceed total return performance, the difference will reduce the Fund's net asset value per share.

    The amounts and sources of distributions reported are only estimates and are being provided to you pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon each Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. Each Fund will send its stockholders a Form 1099-DIV for the calendar year that will illustrate how to report these distributions for federal income tax purposes.

    Fund Performance and Distribution Rate Information:

    Fund

    Average annual total return (in relation to NAV) for the 5-year period ending on 3/31/2025

    Annualized current distribution rate expressed as a percentage of NAV as of 3/31/2025

    Cumulative total return (in relation to NAV) for the fiscal year through 3/31/2025

    Cumulative fiscal year distributions as a percentage of NAV as 3/31/2025

    BKT

    (1.16%)

    8.83%

    3.81%

    2.21%

    DSU

    10.48%

    11.46%

    0.04%

    2.86%

    FRA

    10.42%

    11.88%

    (0.16%)

    2.97%

    BBN

    1.01%

    6.38%

    3.57%

    1.60%

    BGT

    10.57%

    11.82%

    (0.01%)

    2.96%

    HYT

    9.44%

    9.85%

    0.54%

    2.46%

    BTZ

    5.77%

    9.00%

    1.61%

    2.25%

    BLW

    8.35%

    9.85%

    0.62%

    2.46%

    BHK

    0.43%

    8.62%

    2.96%

    2.16%

    BIT

    11.20%

    10.40%

    0.90%

    2.60%

    No conclusions should be drawn about a Fund's investment performance from the amount of the Fund's distributions or from the terms of the Fund's Plan.

    The amount distributed per share under a Plan is subject to change at the discretion of the applicable Fund's Board. Each Plan will be subject to ongoing review by the Board to determine whether the Plan should be continued, modified or terminated. The Board may amend the terms of a Plan or suspend or terminate a Plan at any time without prior notice to the Fund's shareholders if it deems such actions to be in the best interest of the Fund or its shareholders. The amendment or termination of a Plan could have an adverse effect on the market price of the Fund's shares.

    About BlackRock

    BlackRock's purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people build savings that serve them throughout their lives by making investing easier and more affordable. For additional information on BlackRock, please visit www.blackrock.com/corporate.

    Availability of Fund Updates

    BlackRock will update performance and certain other data for the Funds on a monthly basis on its website in the "Closed-end Funds" section of www.blackrock.com as well as certain other material information as necessary from time to time. Investors and others are advised to check the website for updated performance information and the release of other material information about the Funds. This reference to BlackRock's website is intended to allow investors public access to information regarding the Funds and does not, and is not intended to, incorporate BlackRock's website in this release.

    Forward-Looking Statements

    This press release, and other statements that BlackRock or a Fund may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to a Fund's or BlackRock's future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as "trend," "potential," "opportunity," "pipeline," "believe," "comfortable," "expect," "anticipate," "current," "intention," "estimate," "position," "assume," "outlook," "continue," "remain," "maintain," "sustain," "seek," "achieve," and similar expressions, or future or conditional verbs such as "will," "would," "should," "could," "may" or similar expressions.

    BlackRock cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and BlackRock assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.

    With respect to the Funds, the following factors, among others, could cause actual events to differ materially from forward-looking statements or historical performance: (1) changes and volatility in political, economic or industry conditions, the interest rate environment, foreign exchange rates or financial and capital markets, which could result in changes in demand for the Funds or in a Fund's net asset value; (2) the relative and absolute investment performance of a Fund and its investments; (3) the impact of increased competition; (4) the unfavorable resolution of any legal proceedings; (5) the extent and timing of any distributions or share repurchases; (6) the impact, extent and timing of technological changes; (7) the impact of legislative and regulatory actions and reforms, and regulatory, supervisory or enforcement actions of government agencies relating to a Fund or BlackRock, as applicable; (8) terrorist activities, international hostilities, health epidemics and/or pandemics and natural disasters, which may adversely affect the general economy, domestic and local financial and capital markets, specific industries or BlackRock; (9) BlackRock's ability to attract and retain highly talented professionals; (10) the impact of BlackRock electing to provide support to its products from time to time; and (11) the impact of problems at other financial institutions or the failure or negative performance of products at other financial institutions.

    Annual and Semi-Annual Reports and other regulatory filings of the Funds with the Securities and Exchange Commission ("SEC") are accessible on the SEC's website at www.sec.gov and on BlackRock's website at www.blackrock.com, and may discuss these or other factors that affect the Funds. The information contained on BlackRock's website is not a part of this press release.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250430964005/en/

    1-800-882-0052

    Get the next $BBN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BBN
    $BCAT
    $BCX
    $BDJ

    CompanyDatePrice TargetRatingAnalyst
    BlackRock Technology and Private Equity Term Trust
    $BTX
    12/29/2021$9.00Overweight
    Cantor Fitzgerald
    BlackRock Technology and Private Equity Term Trust
    $BTX
    10/6/2021$20.00Buy
    Maxim Group
    More analyst ratings

    $BBN
    $BCAT
    $BCX
    $BDJ
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Certain BlackRock Funds (BGY, BSTZ, MVF) Announce Final Results of Tender Offers

      The BlackRock closed-end funds (the "Funds") listed below announced today the final results of each Fund's tender offer (each, a "Tender Offer") for up to 2.5% of its outstanding common shares (the "Shares"). The Tender Offers, which expired at 5:00 p.m. Eastern time on May 20, 2025, were oversubscribed for each Fund. Therefore, in accordance with the terms and conditions of the Tender Offers, each Fund will purchase Shares from all tendering shareholders on a pro rata basis, after disregarding fractions, based on the number of Shares properly tendered ("Pro-Ration Factor"). The final results of the Tender Offers are provided in the table below. Fund Name Ticker CUSIP Number o

      5/21/25 8:47:00 PM ET
      $BGY
      $BSTZ
      $MVF
      Trusts Except Educational Religious and Charitable
      Finance
      Investment Bankers/Brokers/Service
    • Certain BlackRock Funds (BOE, BCX) Announce Final Results of Tender Offers

      The BlackRock closed-end funds (the "Funds") listed below announced today the final results of each Fund's tender offer (each, a "Tender Offer") for up to 2.5% of its outstanding common shares (the "Shares"). The Tender Offers, which expired at 5:00 p.m. Eastern time on May 19, 2025, were oversubscribed for each Fund. Therefore, in accordance with the terms and conditions of the Tender Offers, each Fund will purchase Shares from all tendering shareholders on a pro rata basis, after disregarding fractions, based on the number of Shares properly tendered ("Pro-Ration Factor"). The final results of the Tender Offers are provided in the table below. Fund Name Ticker CUSIP Number o

      5/20/25 9:53:00 PM ET
      $BCX
      $BOE
      Finance/Investors Services
      Finance
      Trusts Except Educational Religious and Charitable
    • Certain BlackRock Funds (BGY, BSTZ, MVF) Announce Expiration and Preliminary Results of Tender Offers

      The BlackRock closed-end funds (the "Funds") listed below announced today the expiration and preliminary results of each Fund's tender offer (each, a "Tender Offer") for up to 2.5% of its outstanding common shares (the "Shares"). Each Tender Offer commenced on April 17, 2025 and expired at 5:00 p.m. Eastern time on May 20, 2025. Based on preliminary information, the number of Shares properly tendered for each Fund and not withdrawn is noted in the table below. Fund Name Ticker CUSIP Shares Offered for Repurchase Shares Tendered (Preliminary Results) BlackRock Enhanced International Dividend Trust BGY 092524107 2,323,447 22,873,636 BlackRock Science and

      5/20/25 9:23:00 PM ET
      $BGY
      $BSTZ
      $MVF
      Trusts Except Educational Religious and Charitable
      Finance
      Investment Bankers/Brokers/Service

    $BBN
    $BCAT
    $BCX
    $BDJ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Saba Capital Management, L.P. sold $2,741,140 worth of shares (184,539 units at $14.85) (SEC Form 4)

      4 - BlackRock Capital Allocation Term Trust (0001809541) (Issuer)

      5/19/25 6:09:40 PM ET
      $BCAT
      Finance/Investors Services
      Finance
    • SEC Form 3 filed by new insider Minar Stephen Thomas

      3 - BlackRock Resources & Commodities Strategy Trust (0001506289) (Issuer)

      5/16/25 4:30:51 PM ET
      $BCX
      Finance/Investors Services
      Finance
    • New insider Minar Stephen Thomas claimed ownership of 7,745 shares (SEC Form 3)

      3 - BlackRock Science & Technology Term Trust (0001768666) (Issuer)

      5/16/25 4:27:43 PM ET
      $BSTZ
      Trusts Except Educational Religious and Charitable
      Finance

    $BBN
    $BCAT
    $BCX
    $BDJ
    SEC Filings

    See more
    • SEC Form DEF 14A filed by BlackRock Technology and Private Equity Term Trust

      DEF 14A - BlackRock Technology & Private Equity Term Trust (0001836057) (Filer)

      5/22/25 5:04:16 PM ET
      $BTX
    • SEC Form DEFA14A filed by BlackRock ESG Capital Allocation Term Trust

      DEFA14A - BlackRock ESG Capital Allocation Term Trust (0001864843) (Filer)

      5/22/25 6:58:23 AM ET
      $ECAT
      Trusts Except Educational Religious and Charitable
      Finance
    • Amendment: SEC Form SC TO-I/A filed by BlackRock Science and Technology Term Trust

      SC TO-I/A - BlackRock Science & Technology Term Trust (0001768666) (Subject)

      5/21/25 9:14:04 PM ET
      $BSTZ
      Trusts Except Educational Religious and Charitable
      Finance

    $BBN
    $BCAT
    $BCX
    $BDJ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by BlackRock Capital Allocation Term Trust

      SC 13D/A - BlackRock Capital Allocation Term Trust (0001809541) (Subject)

      12/16/24 3:40:56 PM ET
      $BCAT
      Finance/Investors Services
      Finance
    • Amendment: SEC Form SC 13G/A filed by BlackRock Energy and Resources Trust

      SC 13G/A - BlackRock Energy & Resources Trust (0001306550) (Subject)

      12/6/24 4:01:02 PM ET
      $BGR
      Trusts Except Educational Religious and Charitable
      Finance
    • SEC Form SC 13D filed by BlackRock Income Trust Inc.

      SC 13D - BLACKROCK INCOME TRUST, INC. (0000832327) (Subject)

      11/26/24 5:16:13 PM ET
      $BKT
      Investment Bankers/Brokers/Service
      Finance

    $BBN
    $BCAT
    $BCX
    $BDJ
    Financials

    Live finance-specific insights

    See more
    • Amendment: SEC Form SC TO-I/A filed by Blackrock Enhanced International Dividend Trust

      SC TO-I/A - BlackRock Enhanced International Dividend Trust (0001393299) (Subject)

      5/21/25 9:12:51 PM ET
      $BGY
      Trusts Except Educational Religious and Charitable
      Finance
    • Certain BlackRock Funds (BGY, BSTZ, MVF) Announce Final Results of Tender Offers

      The BlackRock closed-end funds (the "Funds") listed below announced today the final results of each Fund's tender offer (each, a "Tender Offer") for up to 2.5% of its outstanding common shares (the "Shares"). The Tender Offers, which expired at 5:00 p.m. Eastern time on May 20, 2025, were oversubscribed for each Fund. Therefore, in accordance with the terms and conditions of the Tender Offers, each Fund will purchase Shares from all tendering shareholders on a pro rata basis, after disregarding fractions, based on the number of Shares properly tendered ("Pro-Ration Factor"). The final results of the Tender Offers are provided in the table below. Fund Name Ticker CUSIP Number o

      5/21/25 8:47:00 PM ET
      $BGY
      $BSTZ
      $MVF
      Trusts Except Educational Religious and Charitable
      Finance
      Investment Bankers/Brokers/Service
    • Amendment: SEC Form SC TO-I/A filed by Blackrock Enhanced Global Dividend Trust

      SC TO-I/A - BlackRock Enhanced Global Dividend Trust (0001320375) (Subject)

      5/20/25 9:37:22 PM ET
      $BOE
      Trusts Except Educational Religious and Charitable
      Finance

    $BBN
    $BCAT
    $BCX
    $BDJ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Portfolio Manager Kim Tony bought $501,390 worth of shares (27,000 units at $18.57), increasing direct ownership by 16% to 193,533 units (SEC Form 4)

      4 - BlackRock Science & Technology Term Trust (0001768666) (Issuer)

      3/14/25 4:39:29 PM ET
      $BSTZ
      Trusts Except Educational Religious and Charitable
      Finance
    • Large owner Saba Capital Management, L.P. bought $200,238 worth of shares (12,099 units at $16.55) (SEC Form 4)

      4 - BlackRock ESG Capital Allocation Term Trust (0001864843) (Issuer)

      3/3/25 10:36:13 AM ET
      $ECAT
      Trusts Except Educational Religious and Charitable
      Finance
    • Large owner Saba Capital Management, L.P. bought $664,754 worth of shares (40,215 units at $16.53) (SEC Form 4)

      4 - BlackRock ESG Capital Allocation Term Trust (0001864843) (Issuer)

      2/27/25 9:58:48 AM ET
      $ECAT
      Trusts Except Educational Religious and Charitable
      Finance

    $BBN
    $BCAT
    $BCX
    $BDJ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald initiated coverage on Brooklyn with a new price target

      Cantor Fitzgerald initiated coverage of Brooklyn with a rating of Overweight and set a new price target of $9.00

      12/29/21 7:03:49 AM ET
      $BTX
    • Maxim Group initiated coverage on Brooklyn ImmunoTherapeutics with a new price target

      Maxim Group initiated coverage of Brooklyn ImmunoTherapeutics with a rating of Buy and set a new price target of $20.00

      10/6/21 7:53:44 AM ET
      $BTX

    $BBN
    $BCAT
    $BCX
    $BDJ
    Leadership Updates

    Live Leadership Updates

    See more
    • Brooklyn ImmunoTherapeutics Announces Changes to Executive Management: Matt Angel, Ph.D. Appointed Interim Chief Executive Officer and President, Andrew Jackson Appointed Chief Financial Officer Postpones 2022 Annual Meeting

      SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) ("Brooklyn" or the "Company"), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have on the immune system for treating patients with cancer, blood disorders, and monogenic diseases, today announced the appointment of Matt Angel, Ph.D., Co-Founder, Chairman, and CEO of Factor Bioscience Inc., as Interim Chief Executive Officer and President. He will replace Howard J. Federoff, M.D., Ph.D., Chief Executive Officer and President, who departs to focus on building a new venture. The Company also announces the appointment of Andrew Jackson as Chief

      5/31/22 7:30:00 AM ET
      $BTX
    • Amarin Announces Appointment of New Directors and Board Leadership Changes

      Erin Enright and Alfonso "Chito" Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with the Company's Strategy Per Wold-Olsen Named Chairman of the Board David Stack and Joe Zakrzewski to Retire from the Board Actions Reflect Company and Board's Commitment to Ongoing Refreshment and Enhancement DUBLIN, Ireland and BRIDGEWATER, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced a series of appointments and leadership changes to its Board of Directors, including: Appointment of Erin Enright and Alfonso "Chito" Zulueta to the Board, effective immediately. Ms. Enright and Mr. Zulueta will sta

      5/19/22 8:23:13 AM ET
      $AMRN
      $BTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors

      NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announces the appointment of two new members of the Company's Board of Directors. Erin S. Enright has served on multiple Boards of Directors, including within the medical and life sciences arenas, such as Keystone Dental (serving as Audit Committee Chair), Medical Facilities Corporation (serving as Audit and Investment Committee Chair), and Dynatronics Corporation (serving on the Audit, Compensati

      1/20/22 7:30:00 AM ET
      $BTX